In recent trading session, ProPhase Labs Inc (NASDAQ:PRPH) saw 4.98 million shares changing hands at last check today with its beta currently measuring -0.41. Company’s recent per share price level of $0.54 trading at -$0.05 or -8.22% at last check today assigns it a market valuation of $16.18M. That most recent trading price of PRPH’s stock is at a discount of -1285.19% from its 52-week high price of $7.48 and is indicating a premium of 59.26% from its 52-week low price of $0.22.
For ProPhase Labs Inc (PRPH), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Upright in the red during last session for losing -8.22%, in the last five days PRPH remained trading in the green while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $0.54 price level, adding 30.77% to its value on the day. ProPhase Labs Inc’s shares saw a change of -28.48% in year-to-date performance and have moved 59.26% in past 5-day. ProPhase Labs Inc (NASDAQ:PRPH) showed a performance of 5.95% in past 30-days.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 96.14% to its recent value today. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -2492.59% in reaching the projected high whereas dropping to the targeted low would mean a loss of -2492.59% for stock’s current value.
ProPhase Labs Inc (PRPH) estimates and forecasts
This year revenue growth is estimated to fall -71.22% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 3.77M for the same. And 1 analysts are in estimates of company making revenue of 2.45M in the next quarter. Company posted 4.35M and 3.63M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -47.90% during past 5 years.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
VANGUARD GROUP INC is the top institutional holder at PRPH for having 0.66 million shares of worth $2.74 million. And as of 2024-06-30, it was holding 3.6351 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 0.22 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.222 of outstanding shares, having a total worth of $0.92 million.
On the other hand, Vanguard Total Stock Market Index Fund and Perritt Microcap Opportunities Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 454.64 shares of worth $0.25 million or 1.90% of the total outstanding shares. The later fund manager was in possession of 190.0 shares on Dec 31, 2024, making its stake of worth around $0.1 million in the company or a holder of 0.80% of company’s stock.
